Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing, and pathological activation. A platform can help align a team of authoritative experts at home and abroad to provide accurate diagnoses and treatments. Individual development of treatment plans for treatment and management of the disorder is often required, including drug therapy, rehabilitation interventions, and regular follow-up management.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, according to the changes of the disease and timely adjustments to the program. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of hematopoiesis.
The platform serves China International Medical Service System, a team of authoritative experts at home and abroad in the field of genetic metabolism, who provide the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.